Streptococcus pyogenes Rosenbach (ATCC® BAA-947)

Strain Designations: MGAS 5005  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations MGAS 5005
Application
Emerging infectious disease research
Isolation
Human clinical specimen, cerebrospinal fluid, Toronto, Ontario, Canada, October 5, 1996
Type Strain no
Biosafety Level 2
Antigenic Properties Serotype M1
Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Genome Sequenced Strain

Streptococcus pyogenes MGAS5005, complete genome.

Type Strain no
Antigenic Properties Serotype M1
Comments
Genome sequenced strain
Name of Depositor JM Musser, D Low
Special Collection ATCC
Isolation
Human clinical specimen, cerebrospinal fluid, Toronto, Ontario, Canada, October 5, 1996
Year of Origin 1996
References

Virtaneva K, et al. Group A Streptococcus gene expression in humans and cynomolgus macaques with acute pharyngitis. Infect. Immun. 71: 2199-2207, 2003. PubMed: 12654842

James M Musser, personal communication

Cross References

Nucleotide (GenBank) : CP000017 Streptococcus pyogenes MGAS5005, complete genome.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation